Stepan Reports Strong Third Quarter Results
Third Quarter Highlights
- Reported net income was
$20.4 million , or$0.89 per diluted share, an 18% decrease versus$24.9 million , or$1.09 per diluted share, in the prior year. Adjusted net income* was$24.5 million , or$1.06 per diluted share, a 16% increase versus$21.1 million , or$0.92 per diluted share, in the prior year. - Total company sales volume increased 2% for the quarter.
- Surfactant operating income was
$20.7 million , a 5% decrease versus prior year. Most of this decrease was attributable to lower sales volumes in Latin American andEurope . Global Surfactant sales volume was flat versus prior year. - Polymer operating income was
$27.1 million , a 10% increase versus prior year. This was mostly attributable to higher volume which was up 11% versus prior year. - The effect of foreign currency translation had an immaterial impact on net income versus prior year.
- On
October 3rd , closed on acquisition of Tebras/PBC inBrazil , which will allow Stepan to expand and diversify its customer base inBrazil and provide an opportunity to sell the Company's broader surfactant portfolio.
Nine Month Highlights
- Reported net income was a record
$75.9 million , or$3.31 per diluted share, a 20% increase versus$63.1 million , or$2.76 per diluted share, in the prior year. Adjusted net income* was a record$84.1 million , or$3.66 per diluted share, a 35% increase versus$62.4 million , or$2.73 per diluted share, in the prior year. - Total company sales volume increased 8% for the first nine months.
- The effect of foreign currency translation negatively impacted net income by
$2.3 million , or$0.10 per diluted share, versus prior year.
* Adjusted net income is a non-GAAP measure which excludes Deferred Compensation income/ expense as well as other significant and infrequent/non-recurring items. See Table II for this non-GAAP reconciliation.
"The Company delivered reported net income of
"Surfactant operating income was down 5% mostly due to lower volumes in
Financial Summary
Three Months Ended |
Nine Months Ended |
||||||||||||||||||||||
($ in thousands, except per share data) |
2016 |
2015 |
% |
2016 |
2015 |
% |
|||||||||||||||||
Net Sales |
$ |
445,030 |
$ |
444,011 |
0 |
% |
$ |
1,345,530 |
$ |
1,356,876 |
(1) |
% |
|||||||||||
Operating Income |
$ |
28,738 |
$ |
38,794 |
(26) |
% |
$ |
116,261 |
$ |
102,567 |
13 |
% |
|||||||||||
Net Income |
$ |
20,427 |
$ |
24,912 |
(18) |
% |
$ |
75,946 |
$ |
63,096 |
20 |
% |
|||||||||||
Earnings per Diluted Share |
$ |
0.89 |
$ |
1.09 |
(18) |
% |
$ |
3.31 |
$ |
2.76 |
20 |
% |
|||||||||||
Adjusted Net Income * |
$ |
24,510 |
$ |
21,098 |
16 |
% |
$ |
84,065 |
$ |
62,441 |
35 |
% |
|||||||||||
Adjusted Earnings per Diluted Share * |
$ |
1.06 |
$ |
0.92 |
15 |
% |
$ |
3.66 |
$ |
2.73 |
34 |
% |
|||||||||||
* See Table II for a reconciliation of non-GAAP Adjusted Net Income and Earnings per Diluted Share. |
Summary of Third Quarter Adjusted Net Income Items
Adjusted net income excludes non-operational deferred compensation income/expense and may exclude certain other significant and infrequent or non-recurring items.
- Deferred Compensation: The current year quarter includes
$6.6 million of pre-tax expense versus$6.2 million of pre-tax income in the prior year. These amounts were$4.1 million of expense and$3.8 million of income, respectively, on an after-tax basis.
Percentage Change in Net Sales
Quarterly net sales were essentially flat versus prior year. Higher sales volume offset lower selling prices and the negative impact of foreign currency translation resulting from the stronger U.S. dollar. Sales volumes were up 2% mostly due to strong Polymer growth globally and higher volumes in North America Surfactants. The lower selling prices were primarily related to lower raw material costs within the Polymer segment.
Three Months Ended |
Nine Months Ended |
|||||||
Volume |
2 |
% |
8 |
% |
||||
Selling Price |
(1) |
% |
(6) |
% |
||||
Foreign Translation |
(1) |
% |
(3) |
% |
||||
Total |
0 |
% |
(1) |
% |
Segment Results
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2016 |
2015 |
% |
2016 |
2015 |
% |
||||||||||||||||||
Net Sales |
||||||||||||||||||||||||
Surfactants |
$ |
290,467 |
$ |
290,830 |
0 |
% |
$ |
899,014 |
$ |
921,124 |
(2) |
% |
||||||||||||
Polymers |
$ |
134,144 |
134,726 |
0 |
% |
$ |
382,540 |
377,703 |
1 |
% |
||||||||||||||
Specialty Products |
$ |
20,419 |
18,455 |
11 |
% |
$ |
63,976 |
58,049 |
10 |
% |
||||||||||||||
Total Net Sales |
$ |
445,030 |
$ |
444,011 |
0 |
% |
$ |
1,345,530 |
$ |
1,356,876 |
(1) |
% |
||||||||||||
Three Months Ended September 30 |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands, all amounts pre-tax) |
2016 |
2015 |
% |
2016 |
2015 |
% |
||||||||||||||||||
Operating Income * |
||||||||||||||||||||||||
Surfactants |
$ |
20,737 |
$ |
21,762 |
(5) |
% |
$ |
85,214 |
$ |
79,758 |
7 |
% |
||||||||||||
Polymers |
$ |
27,087 |
$ |
24,588 |
10 |
% |
$ |
80,278 |
$ |
62,802 |
28 |
% |
||||||||||||
Specialty Products |
$ |
2,328 |
$ |
(268) |
NM |
$ |
6,449 |
$ |
3,498 |
84 |
% |
Total segment operating income increased
- Surfactant net sales were
$290.5 million for the quarter,$0.4 million less than prior year. Sales volume was flat with prior year. Increased North American laundry business was offset by lower volumes inLatin America andEurope . Selling prices were slightly higher resulting in an increase in net sales of$5.3 million while the translation impact of a stronger U.S. dollar decreased net sales by$4.7 million . Surfactant operating income decreased$1.0 million , or 5%, versus the prior year. This decrease was primarily attributable to lower sales volumes inLatin America andEurope as well as accelerated depreciation related to the Canadian plant closure. These were partially offset by lower raw material costs and contributions from our internal efficiency program (DRIVE). - Polymer net sales were
$134.1 million in the third quarter, a$0.6 million decrease versus prior year. Sales volume increased 11% in the quarter primarily due to continued growth in polyols used in rigid foam insulation and insulated metal panels. Net sales increased$14.4 million as a result of this volume growth. Selling prices were lower which decreased net sales by$13.4 million . The translation impact of a stronger U.S. dollar decreased net sales by$1.6 million . Operating income increased$2.5 million , or 10%, versus the prior year. This improvement was primarily attributable to 14% volume growth within the Global Rigid Polyol business. - Specialty Products net sales were
$20.4 million ,$2.0 million higher than prior year. Operating income increased$2.5 million versus the prior year. This improvement was primarily due to higher volumes, improved margins and lower costs due to actions taken in 2015.
Corporate Expenses
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||
($ in thousands) |
2016 |
2015 |
% |
2016 |
2015 |
% |
||||||||||||||||||
Total - Corporate Expenses |
$ |
21,414 |
$ |
7,288 |
194 |
% |
$ |
55,680 |
$ |
43,491 |
28 |
% |
||||||||||||
Deferred Compensation Expense/(Income) * |
$ |
7,441 |
$ |
(6,922) |
(207) |
% |
$ |
12,595 |
$ |
1,228 |
926 |
% |
||||||||||||
Adjusted Corporate Expense |
$ |
13,973 |
$ |
14,210 |
(2) |
% |
$ |
43,085 |
$ |
42,263 |
2 |
% |
||||||||||||
* See Table III for a discussion of deferred compensation plan accounting. |
||||||||||||||||||||||||
- Corporate expenses, excluding deferred compensation, decreased
$0.2 million , or 2%, for the quarter. This decrease was mostly attributable to lower consulting expenses, as external resources related to our efficiency efforts were not used in the current year, and lower expat expenses. These decreases were partially offset by higher incentive-based compensation expenses.
Income Taxes
The effective tax rate was 29% for the first nine months of 2016, which was slightly higher than the 28% rate for the first nine months of 2015.
Selected Balance Sheet Information
The Company's net debt level decreased
($ in millions) |
9/30/16 |
6/30/16 |
3/31/16 |
12/31/15 |
||||||||||||
Net Debt |
||||||||||||||||
Total Debt |
$ |
326.1 |
$ |
321.4 |
$ |
327.9 |
$ |
331.4 |
||||||||
Cash |
207.0 |
190.4 |
145.7 |
176.1 |
||||||||||||
Net Debt |
$ |
119.1 |
$ |
131.0 |
$ |
182.2 |
$ |
155.3 |
||||||||
Equity |
638.4 |
618.9 |
594.8 |
557.0 |
||||||||||||
Net Debt + Equity |
$ |
757.5 |
$ |
749.9 |
$ |
777.0 |
$ |
712.3 |
||||||||
Net Debt / (Net Debt + Equity) |
16 |
% |
17 |
% |
23 |
% |
22 |
% |
The major working capital components were:
($ in millions) |
9/30/16 |
6/30/16 |
3/31/16 |
12/31/15 |
||||||||||||
Net Receivables |
$ |
281.1 |
$ |
285.1 |
$ |
291.6 |
$ |
249.6 |
||||||||
Inventories |
184.0 |
180.7 |
177.8 |
170.4 |
||||||||||||
Accounts Payable |
(129.1) |
(144.2) |
(130.0) |
(128.6) |
||||||||||||
$ |
336.0 |
$ |
321.6 |
$ |
339.4 |
$ |
291.4 |
The Company had capital expenditures of
Outlook
"After a record nine months, we anticipate headwinds in the fourth quarter due to higher raw material costs versus fourth quarter of 2015, scheduled maintenance shutdown of our phthalic anhydride unit and accelerated depreciation resulting from the closure of our Canadian plant," said
Conference Call
Supporting Slides
Slides supporting this press release will be made available at www.stepan.com under the Investor Relations center at approximately the same time as this press release is issued.
Corporate Profile
Headquartered in
The common stock is traded on the
Contact:
* * * * *
Tables follow
Except for historical information, all other information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected, anticipated or implied. Significant risks and uncertainties are described in
Table I |
||||||||||||||||
STEPAN COMPANY |
||||||||||||||||
For the Three and Nine Months Ended September 30, 2016 and 2015 |
||||||||||||||||
(Unaudited – in thousands, except per share data) |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
2016 |
2015 |
2016 |
2015 |
|||||||||||||
Net Sales |
$ |
445,030 |
$ |
444,011 |
$ |
1,345,530 |
$ |
1,356,876 |
||||||||
Cost of Sales |
361,635 |
366,413 |
1,075,705 |
1,123,324 |
||||||||||||
Gross Profit |
83,395 |
77,598 |
269,825 |
233,552 |
||||||||||||
Operating Expenses: |
||||||||||||||||
Selling |
13,990 |
14,025 |
42,252 |
41,287 |
||||||||||||
Administrative * |
18,958 |
19,076 |
55,350 |
54,320 |
||||||||||||
Research, Development and Technical Services |
14,268 |
12,625 |
42,306 |
37,012 |
||||||||||||
Deferred Compensation (Income) Expense * |
7,441 |
(6,922) |
12,595 |
1,228 |
||||||||||||
54,657 |
38,804 |
152,503 |
133,847 |
|||||||||||||
Other Operating Income (Expense) |
||||||||||||||||
Gain on Sale of Product Line |
- |
- |
- |
2,862 |
||||||||||||
Business Restructuring |
- |
- |
(1,061) |
- |
||||||||||||
Operating Income |
28,738 |
38,794 |
116,261 |
102,567 |
||||||||||||
Other Income (Expense): |
||||||||||||||||
Interest, Net |
(2,824) |
(3,837) |
(9,855) |
(10,760) |
||||||||||||
Loss from Equity in Joint Venture |
- |
(863) |
- |
(3,918) |
||||||||||||
Other, Net |
1,229 |
(981) |
401 |
(94) |
||||||||||||
(1,595) |
(5,681) |
(9,454) |
(14,772) |
|||||||||||||
Income Before Income Taxes |
27,143 |
33,113 |
106,807 |
87,795 |
||||||||||||
Provision for Income Taxes |
6,711 |
8,179 |
30,848 |
24,634 |
||||||||||||
Net Income |
20,432 |
24,934 |
75,959 |
63,161 |
||||||||||||
Net Income Attributable to Noncontrolling Interests |
(5) |
(22) |
(13) |
(65) |
||||||||||||
Net Income Attributable to Stepan Company |
$ |
20,427 |
$ |
24,912 |
$ |
75,946 |
$ |
63,096 |
||||||||
Net Income Per Common Share Attributable to Stepan Company |
||||||||||||||||
Basic |
$ |
0.90 |
$ |
1.10 |
$ |
3.34 |
$ |
2.78 |
||||||||
Diluted |
$ |
0.89 |
$ |
1.09 |
$ |
3.31 |
$ |
2.76 |
||||||||
Shares Used to Compute Net Income Per Common Share Attributable to Stepan Company |
||||||||||||||||
Basic |
22,819 |
22,732 |
22,771 |
22,731 |
||||||||||||
Diluted |
23,082 |
22,853 |
22,975 |
22,851 |
||||||||||||
* For the three and nine months ended September 30, 2015, deferred compensation (income)/expense was included in administrative expenses. The 2015 amounts have been classified separately to conform to the current year presentation. |
Table II |
||||||||||||||||||||||||||||||||
Reconciliation of Non-GAAP Net Income and Earnings Per Diluted Share |
||||||||||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2016 |
EPS |
2015 |
EPS |
2016 |
EPS |
2015 |
EPS |
||||||||||||||||||||||||
Net Income Reported |
$ |
20,427 |
$ |
0.89 |
$ |
24,912 |
$ |
1.09 |
$ |
75,946 |
$ |
3.31 |
$ |
63,096 |
$ |
2.76 |
||||||||||||||||
Deferred Compensation (Income) Expense |
$ |
4,083 |
$ |
0.17 |
(3,814) |
$ |
(0.17) |
$ |
7,323 |
$ |
0.32 |
778 |
$ |
0.03 |
||||||||||||||||||
Business Restructuring |
— |
— |
— |
— |
$ |
796 |
$ |
0.03 |
— |
|||||||||||||||||||||||
Environmental Remediation Expense |
— |
— |
— |
— |
— |
— |
341 |
$ |
0.01 |
|||||||||||||||||||||||
Gain on Divestiture of Product Line |
— |
— |
— |
— |
— |
— |
(1,774) |
$ |
(0.08) |
|||||||||||||||||||||||
Adjusted Net Income |
$ |
24,510 |
$ |
1.06 |
$ |
21,098 |
$ |
0.92 |
$ |
84,065 |
$ |
3.66 |
$ |
62,441 |
$ |
2.73 |
||||||||||||||||
* All amounts in this table are presented after-tax |
||||||||||||||||||||||||||||||||
The Company believes that certain non-GAAP measures, when presented in conjunction with comparable GAAP (Generally Accepted Accounting Principles) measures, are useful for evaluating the Company's operating performance and provide better clarity on the impact of non operational items. Internally, the Company uses this non-GAAP information as an indicator of business performance, and evaluates management's effectiveness with specific reference to these indicators. These measures should be considered in addition to, and are neither a substitute for, nor superior to, measures of financial performance prepared in accordance with GAAP. |
||||||||||||||||||||||||||||||||
Reconciliation of Pre-Tax to After-Tax Adjustments |
||||||||||||||||||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||||||||||||||||||
($ in thousands, except per share amounts) |
2016 |
EPS |
2015 |
EPS |
2016 |
EPS |
2015 |
EPS |
||||||||||||||||||||||||
Pre-Tax Adjustments |
||||||||||||||||||||||||||||||||
Deferred Compensation (Income) Expense |
$ |
6,585 |
$ |
(6,152) |
$ |
11,811 |
$ |
1,255 |
||||||||||||||||||||||||
Business Restructuring |
— |
— |
$ |
1,061 |
— |
|||||||||||||||||||||||||||
Environmental Remediation Expense |
— |
— |
— |
$ |
550 |
|||||||||||||||||||||||||||
Gain on Divestiture of Product Line |
— |
— |
— |
$ |
(2,862) |
|||||||||||||||||||||||||||
Total Pre-Tax Adjustments |
$ |
6,585 |
$ |
(6,152) |
$ |
12,872 |
$ |
(1,057) |
||||||||||||||||||||||||
Cumulative Tax Effect on Adjustments |
$ |
(2,502) |
$ |
2,338 |
$ |
(4,753) |
$ |
402 |
||||||||||||||||||||||||
After-Tax Adjustments |
$ |
4,083 |
$ |
0.17 |
$ |
(3,814) |
$ |
(0.17) |
$ |
8,119 |
$ |
0.35 |
$ |
(655) |
$ |
(0.03) |
Table III |
||||||||||||||||||||||||||||||
Deferred Compensation Plan |
||||||||||||||||||||||||||||||
The full effect of the deferred compensation plan on quarterly pretax income was $6.6 million of expense versus $6.2 million of income in the prior year. The year to date impact was $11.8 million of expense versus $1.3 million of expense in the prior year. The accounting for the deferred compensation plan results in operating income when the price of Stepan Company common stock or mutual funds held in the plan fall and expense when they rise. The Company also recognizes the change in value of mutual funds as investment income or loss. The quarter end market prices of Stepan Company common stock are as follows: |
||||||||||||||||||||||||||||||
2016 |
2015 |
|||||||||||||||||||||||||||||
12/31 |
9/30 |
6/30 |
3/31 |
12/31 |
9/30 |
6/30 |
3/31 |
|||||||||||||||||||||||
Stepan Company |
N/A |
$ |
72.66 |
$ |
59.53 |
$ |
55.29 |
$ |
49.69 |
$ |
41.61 |
$ |
54.11 |
$ |
41.66 |
|||||||||||||||
The deferred compensation income statement impact is summarized below: |
||||||||||||||||
Three Months Ended |
Nine Months Ended |
|||||||||||||||
($ in thousands) |
2016 |
2015 |
2016 |
2015 |
||||||||||||
Deferred Compensation |
||||||||||||||||
Operating Income (Expense) |
$ |
(7,441) |
$ |
6,922 |
$ |
(12,595) |
$ |
(1,228) |
||||||||
Other, net – Mutual Fund Gain (Loss) |
856 |
(770) |
784 |
(27) |
||||||||||||
Total Pretax |
$ |
(6,585) |
$ |
6,152 |
$ |
(11,811) |
$ |
(1,255) |
||||||||
Total After Tax |
$ |
(4,083) |
$ |
3,814 |
$ |
(7,323) |
$ |
(778) |
Table IV |
||||||||||||||||||||||||||||||||
Effects of Foreign Currency Translation |
||||||||||||||||||||||||||||||||
The Company's foreign subsidiaries transact business and report financial results in their respective local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). Below is a table that presents the impact that foreign currency translation had on the changes in consolidated net sales and various income line items for the three and nine month periods ending September 30, 2016 as compared to 2015: |
||||||||||||||||||||||||||||||||
($ in millions) |
Three Months Ended |
Increase (Decrease) |
(Decrease) Due to Foreign Currency Translation |
Nine Months Ended |
Increase (Decrease) |
(Decrease) Due to Foreign Currency Translation |
||||||||||||||||||||||||||
2016 |
2015 |
2016 |
2015 |
|||||||||||||||||||||||||||||
Net Sales |
$ |
445.0 |
$ |
444.0 |
$ |
1.0 |
$ |
(6.3) |
$ |
1,345.5 |
$ |
1,356.9 |
$ |
(11.4) |
$ |
(34.8) |
||||||||||||||||
Gross Profit |
83.4 |
77.6 |
5.8 |
(0.4) |
269.8 |
233.6 |
36.2 |
(5.5) |
||||||||||||||||||||||||
Operating Income |
28.7 |
38.8 |
(10.1) |
(0.1) |
116.3 |
102.6 |
13.7 |
(3.4) |
||||||||||||||||||||||||
Pretax Income |
27.1 |
33.1 |
(6.0) |
(0.1) |
106.8 |
87.8 |
19.0 |
(3.3) |
Table V |
||||||||
Stepan Company |
||||||||
Consolidated Balance Sheets |
||||||||
September 30, 2016 and December 31, 2015 |
||||||||
2016 |
2015 |
|||||||
ASSETS |
||||||||
Current Assets |
$ |
696,332 |
$ |
619,573 |
||||
Property, Plant & Equipment, Net |
573,698 |
555,463 |
||||||
Other Assets |
61,060 |
63,356 |
||||||
Total Assets |
$ |
1,331,090 |
$ |
1,238,392 |
||||
LIABILITIES AND STOCKHOLDERS' EQUITY |
||||||||
Current Liabilities |
$ |
244,723 |
$ |
243,244 |
||||
Deferred Income Taxes |
13,187 |
9,455 |
||||||
Long-term Debt |
306,478 |
312,548 |
||||||
Other Non-current Liabilities |
126,970 |
114,761 |
||||||
Total Stepan Company Stockholders' Equity |
638,356 |
556,984 |
||||||
Noncontrolling Interest |
1,376 |
1,400 |
||||||
Total Liabilities and Stockholders' Equity |
$ |
1,331,090 |
$ |
1,238,392 |
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/stepan-reports-strong-third-quarter-results-300346390.html
SOURCE